A Reminder of Methylene Blue’s Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery
The use of methylene blue should be considered in patients who develop hypotension refractory to standard treatment after cardiac surgery.
World's Largest Resource for Cardiovascular Perfusion
The use of methylene blue should be considered in patients who develop hypotension refractory to standard treatment after cardiac surgery.
Perfusion.com Jobs: We are always seeking out the best and brightest current and future leaders for employment opportunities within our company.
The present double-blind randomized study is designed to evaluate the effectiveness of autologous PRF in the treatment of mandibular degree II furcation defects compared with open flap debridement (OFD).